Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII | NASDAQ
$10.21
+$0.01 (+0.10%)
Nov 2, 2026, 9:36 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
PE Ratio | 61.88 | -4.12K |
PEG Ratio | -0.01 | n/a |
PS Ratio | n/a | n/a |
PB Ratio | 0.27 | -5.39K |
P/FCF Ratio | -129.19 | -3.24K |
P/OCF Ratio | -129.19 | -3.24K |
OCF/S Ratio | n/a | n/a |
Debt / Equity Ratio | n/a | -2.14 |
Quick Ratio | 0.09 | 0.23 |
Current Ratio | 0.09 | 0.23 |
Asset Turnover | n/a | n/a |
Interest Coverage | n/a | n/a |
Return on Equity | 0.86% | 129.99% |
Return on Assets | 0.83% | -109.89% |
Return on Invested Capital | -0.26% | -113.75% |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | n/a | n/a |
Net Profit Margin | n/a | n/a |
Pretax Profit Margin | n/a | n/a |
Operating Profit Margin | n/a | n/a |
FCF Margin | n/a | n/a |
EBITDA Margin | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DMII